Template properties of mutagenic cytosine analogues in reverse transcription

Nucleic Acids Research

Volumn 34, Issue 22, 2006, Pages 6438-6449

  Suzuki, Tetsuya ^a   Moriyama, Kei ^b   Otsuka, Chie ^c   Loakes, David ^d   Negishi, Kazuo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b SHUJITSU UNIVERSITY   (Japan)

^c Research Institute for Biological Science OKAYAMA   (Japan)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 N HYDROXYCYTIDINE; 4 N METHOXYCYTIDINE; 4 N METHOXYCYTIDINE TRIPHOSPHATE; 4 N METHYLCYTIDINE; 4 SEMICARBAZIDOCYTIDINE; 4 SEMICARBAZIDOCYTIDINE 5' TRIPHOSPHATE; 6 (BETA DEXTRO RIBOFURANOSYL) 3,4 DIHYDRO 8H PYRIMIDOL[4,5][1,2]OXACIN 7 ONE; 6 (BETA DEXTRO RIBOFURANOSYL) 3,4 DIHYDRO 8H PYRIMIDOL[4,5][1,2]OXACIN 7 ONE 5' TRIPHOSPHATE; ANTIRETROVIRUS AGENT; CYTOSINE DERIVATIVE; DEOXYADENOSINE PHOSPHATE; DEOXYGUANOSINE PHOSPHATE; DEOXYRIBONUCLEOSIDE TRIPHOSPHATE; GENOMIC RNA; N4 HYDROXYCYTIDINE 5' TRIPHOSPHATE; N4 METHYLCYTIDINE 5' TRIPHOSPHATE; NUCLEOTIDE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA POLYMERASE; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BASE PAIRING; DNA TEMPLATE; DRUG SYNTHESIS; ENZYME SPECIFICITY; ENZYME STRUCTURE; MUTAGENESIS; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; RNA SYNTHESIS; VIRUS MUTATION;

ANTI-RETROVIRAL AGENTS; CYTIDINE; DEOXYRIBONUCLEOTIDES; DNA-DIRECTED RNA POLYMERASES; HELA CELLS; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; KINETICS; MUTAGENESIS; RETROVIRIDAE; REVERSE TRANSCRIPTION; RIBONUCLEOTIDES; RNA POLYMERASE II; TEMPLATES, GENETIC;

EID: 33845893019     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl761     Document Type: Article

References (57)

1. Ho,D.D., Neumann,A.U., Perelson,A.S., Chen,W., Leonard,J.M. and Markowitz,M. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 373, 123-126.
2. Coffin,J.M. (1995) HIV population dynamics in vivo: Implication for genetic variation, pathogenesis, and therapy. Science, 267, 483-489.
3. Domingo,E. (2000) Viruses at the edge of adaptation. Virology, 270, 251-253.
4. Crotty,S., Cameron,C.E. and Andino,R. (2001) RNA virus error catastrophe: Direct molecular test by using ribavirin. Proc. Natl Acad. Sci. USA, 98, 6895-6900.
5. Graci,J.D. and Cameron,C.E. (2002) Quasispecies, error catastrophe, and the antiviral activity of ribavirin. Virology, 298, 175-180.
6. Loeb,L.A., Essigmann,J.M., Kazazi,F., Zhang,J., Rose,K.D. and Mullins,J.I. (1999) Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc. Natl Acad. Sci. USA, 96, 1492-1497.
7. Cameron,C.E. and Castro,C. (2001) The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase. Curr. Opin. Infect. Dis., 14, 757-764.
8. Crotty,S., Maag,D., Arnold,J.J., Zhong,W., Lau,J.Y.N., Hong,Z., Andino,R. and Cameron,C.E. (2000) The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nature Med., 6, 1375-1379.
9. Severson,W.E., Schmaljohn,C.S., Javadian,A. and Jonsson,C.B. (2003) Ribavirin causes error catastrophe during Hantaan virus replication. J. Virol., 77, 481-488.
10. Holland,J.J., Domingo,E., de la Torre,J.C. and Steinhauer,D.A. (1990) Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J. Virol., 64, 3960-3962.
11. Sierra,S., Davila,M., Lowenstein,P.R. and Domingo,E. (2000) Response of foot-and-mouth disease virus to increased mutagenesis: Influence of viral load and fitness in loss of infectivity. J. Virol., 74, 8316-8323.
12. Grande-Pérez,A., Sierra,S., Castro,M.G., Domingo,E. and Lowenstein,P.R. (2002) Molecular indetermination in the transition to error catastrophe: Systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc. Natl Acad. Sci. USA, 99, 2938-2943.
13. Ruiz-Jarabo,C.M., Ly,C., Domingo,E. and de la Torre,J.C. (2003) Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology, 308, 37-47.
14. Harris,K.S., Brabant,W., Styrchak,S., Gall,A. and Daifuku,R. (2005) KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis. Antiviral Res., 67, 1-9.
15. Ross,J. (1996) Control of messenger RNA stability in higher eukaryotes. Trends Genet., 12, 171-175.
16. Heintz,N., Sive,H.L. and Roeder,R.G. (1983) Regulation of human histone gene expression: Kinetics of accumulation and changes in the rate of synthesis and in the half-lives of individual histone mRNAs during the HeLa cell cycle. Mol. Cell. Biol., 3, 539-550.
17. Bowie,J.U., Reidhaar-Olson,J.F., Lim,W.A. and Sauer,R.T. (1990) Deciphering the message in protein sequences: Tolerance to amino acid substitutions. Science, 247, 1306-1310.
18. Guo,H.H., Choe,J. and Loeb,L.A. (2004) Protein tolerance to random amino acid change. Proc. Natl Acad. Sci. USA, 101, 9205-9210.
19. Patel,P.H. and Loeb,L.A. (2000) DNA polymerase active site is highly mutable: Evolutionary consequences. Proc. Natl Acad. Sci. USA, 97, 5095-5100.
20. Loeb,L.A. and Mullins,J.I. (2000) Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs. AIDS Res. Hum. Retroviruses, 16, 1-3.
21. Moriyama,K., Otsuka,C., Loakes,D. and Negishi,K. (2001) Highly efficient random mutagenesis in transcription-reverse-transcription cycles by a hydrogen bond ambivalent nucleoside 5′-triphosphate analogue: potential candidates for a selective anti-retroviral therapy. Nucleosides Nucleotides Nucleic Acids, 20, 1473-1483.
22. Singer,B. and Spengler,S. (1981) Ambiguity and transcriptional errors as a result of modification of exocyclic amino groups of cytidine, guanosine, and adenosine. Biochemistry, 20, 1127-1132.
23. 4-Methoxydeoxycytidine triphosphate is in the imino tautomeric form and substitutes for deoxythymidine triphosphate in primed poly d[A-T] synthesis with E.coli DNA polymerase I. Nucleic Acids Res., 12, 4609-4619.
24. 4-methoxydeoxycytidine 5′-triphosphate during DNA synthesis on natural templates, catalyzed by DNA polymerase I of Escherichia coli. Biochemistry, 24, 2262-2268.
25. 4-aminocytidine: Induction of AT to GC transition and its molecular mechanism. Biochemistry, 24, 7273-7278.
26. 4-aminocytidine-mediated replicational errors. Mol. Cell. Biol., 8, 347-352.
27. Moriyama,K., Okada,T. and Negishi,K. (2002) In Loakes,D. (ed.), Recent Research Developments in Organic and Bioorganic Chemistry. Transworld Research Network, Kerala, Vol. 5, pp. 152-161.
28. Brown,D., Hewlins,M. and Schell,P. (1968) The tautomeric state of N(4)-hydroxy- and N(4)-amino-cytosine derivatives. J. Chem. Soc., 15, 1925-1929.
29. Harris,V.H., Smith,C.L., Cummins,W.J., Hamilton,A.L., Adams,H., Dickman,M., Hornby,D.P. and Williams,D.M. (2003) The effect of tautomeric constant on the specificity of nucleotide incorporation during DNA replication: Support for the rare tautomer hypothesis of substitution mutagenesis. J. Mol. Biol., 326, 1389-1401.
30. Grice,S.F.L. and Gruninger-Leitch,F. (1990) Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. Eur. J. Biochem., 187, 307-314.
31. Budowsky,E.I., Sverdlov,E.D. and Spasokukotskaya,T.N. (1972) Mechanism of the mutagenic action of hydroxylamine VII. Functional activity and specificity of cytidine triphosphate modified with hydroxylamine and O-methylhydroxylamine. Biochim. Biophys. Acta, 287, 195-210.
32. Shapiro,R. and Weisgras,J.M. (1970) Bisulfite-catalyzed transamination of cytosine and cytidine. Biochem. Biophys. Res. Commun., 40, 839-843.
33. Hayatsu,H. (1976) Reaction of cytidine with semicarbazide in the presence of bisulfite. A rapid modification specific for single-stranded polynucleotide. Biochemistry, 15, 2677-2682.
34. Moriyama,K., Negishi,K., Briggs,M.S., Smith,C.L., Hill,F., Churcher,M.J., Brown,D.M. and Loakes,D. (1998) Synthesis and RNA polymerase incorporation of the degenerate ribonucleotide analogue rPTP. Nucleic Acids Res., 26, 2105-2111.
35. Eadie,J., McBride,L., Efcavitch,J., Hoff,L. and Cathcart,R. (1987) High-performance liquid chromatographic analysis of oligodeoxyribonucleotide base composition. Anal. Biochem., 165, 442-447.
36. Petruska,J., Goodman,M.F., Boosalis,M.S., Sowers,L.C., Cheong,C. and Tinoco,I., Jr (1988) Comparison between DNA melting thermodynamics and DNA polymerase fidelity. Proc. Natl Acad. Sci. USA, 85, 6252-6256.
37. Yu,H. and Goodman,M.F. (1992) Comparison of HIV-1 and avian virus reverse transcriptase fidelity on RNA and DNA templates. J. Biol. Chem., 267, 10888-10896.
38. Negishi,K., Bessho,T. and Hayatsu,H. (1994) Nucleoside and nucleobase analog mutagens. Mutat. Res., 318, 227-238.
39. Meervelt,L.V., Lin,P.K.T. and Brown,D.M. (1995) 6-(3,5-Di-O-acethyl-β-D-2-deoxyribofuranosyl -3,4-dihydro-8H-pyrimido [4,5-c][1,2]-oxazin-7(6H)-one. Acta. Crystallogr. sect. C, 51, 1347-1350.
40. 4-hydroxy-5-fluorocytosine. A theoretical ab initio study. Biochim. Biophys. Acta, 1173, 39-48.
41. 4-methoxycytosine. Acta. Crystallogr. sect. C, 47, 2635-2637.
42. 4-hydroxycytosine. Biochim. Biophys. Acta, 447, 274-284.
43. 1H nuclear magnetic resonance studies of base-modified oligodeoxynucleotides. J. Mol. Biol., 222, 711-723.
44. 1H nuclear magnetic resonance studies of oligodeoxynucleotide duplexes containing base-modified cytosine residues. J. Mol. Biol., 230, 1068-1076.
45. Hossain,M.T., Chatake,T., Hikima,T., Tsunoda,M., Sunami,T., Ueno,Y., Matsuda,A. and Takenaka,A. (2001) Crystallographic studies on damaged DNAs:III. N4-methoxycytosine can form both Watson-Crick type and wobbled base pars in a B-form duplex. J. Biochem., 130, 9-12.
46. Fazakerley,G.V., Gdaniec,Z. and Sowers,L.C. (1993) Base-pair induced shifts in the tautomeric equilibrium of a modified DNA base. J. Mol. Biol., 230, 6-10.
47. 4-aminocytidine and its derivatives in Chinese hamster lung V79 cells. Incorporation of N4-aminocytosine into cellular DNA. Mutat. Res., 177, 283-287.
48. 4-aminocytosine. Biochem. Biophys. Res. Commun., 153, 552-557.
49. Oussoren,C., Magnani,M., Fraternale,A., Casabianca,A., Chiarantini,L., Ingebrigsten,R., Underberg,W. and Storm,G. (1999) Liposomes as carriers of the antiretroviral agent dideoxycytidine-5′-triphosphate. Int. J. Pharm., 180, 261-270.
50. Zelphati,O., Degols,G., Loughrey,H., Leserman,L., Pompon,A., Puech,F., Maggio,A., Imbach,J. and Gosselin,G. (1993) Inhibition of HIV-1 replication in cultured cells with phosphorylated dideoxyuridine derivatives encapsulated in immunoliposomes. Antiviral Res., 21, 181-195.
51. Wagner,C.R., Iyer,V.V. and McIntee,E.J. (2000) Pronucleotides: Toward the in vivo delivery of antiviral and anticancer nucleotides. Med. Res. Rev., 20, 417-451.
52. Prang,K., Wiebe,L. and Knaus,E. (2000) Novel approaches for designing 5′-O-ester prodrugs of 3′-azido-2′, 3′-dideoxythymidine (AZT). Curr. Med. Chem., 7, 995-1039.
53. Traut,T. (1994) Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem., 140, 1-22.
54. Pariente,N., Sierra,S. and Airaksinen,A. (2005) Action of mutagenic agents and antiviral inhibitors on foot-and-mouth disease virus. Virus Res., 107, 183-193.
55. Pariente,N., Sierra,S., Lowenstein,P.R. and Domingo,E. (2001) Efficient virus extinction by combinations of a mutagen and antiviral inhibitors. J. Virol., 75, 9723-9730.
56. Pariente,N., Airaksinen,A. and Domingo,E. (2003) Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus. J. Virol., 77, 7131-7138.
57. Gerrish,P.J. and García-Lerma,J.G. (2003) Mutation rate and the efficacy of antimicrobial drug treatment. Lancet Infect. Dis., 3, 28-32.